158 related articles for article (PubMed ID: 8285609)
1. Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis.
Klietmann W; Cesana M; Rondel RK; Focht J
Antimicrob Agents Chemother; 1993 Nov; 37(11):2298-306. PubMed ID: 8285609
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
Langan CE; Cranfield R; Breisch S; Pettit R
J Antimicrob Chemother; 1997 Dec; 40 Suppl A():63-72. PubMed ID: 9484875
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.
Chodosh S; Lakshminarayan S; Swarz H; Breisch S
Antimicrob Agents Chemother; 1998 Jan; 42(1):114-20. PubMed ID: 9449270
[TBL] [Abstract][Full Text] [Related]
4. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
DeAbate CA; Henry D; Bensch G; Jubran A; Chodosh S; Harper L; Tipping D; Talbot GH
Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
[TBL] [Abstract][Full Text] [Related]
5. Treatment of acute exacerbations of chronic bronchitis: comparison of trovafloxacin and amoxicillin in a multicentre, double-blind, double-dummy study. Trovafloxacin Bronchitis Study Group.
O'Doherty B; Daniel R
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):441-6. PubMed ID: 9758290
[TBL] [Abstract][Full Text] [Related]
6. Gemifloxacin versus amoxicillin/clavulanate in the treatment of acute exacerbations of chronic bronchitis. The 070 Clinical Study group.
File T; Schlemmer B; Garau J; Lode H; Lynch S; Young C
J Chemother; 2000 Aug; 12(4):314-25. PubMed ID: 10949981
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis.
Gotfried MH; Ellison WT
Am J Med; 1992 Apr; 92(4A):108S-113S. PubMed ID: 1316059
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ
Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
[TBL] [Abstract][Full Text] [Related]
9. A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology.
Kemper P; Köhler D
Am J Med; 1992 Apr; 92(4A):98S-102S. PubMed ID: 1316079
[TBL] [Abstract][Full Text] [Related]
10. Rufloxacin once daily versus ciprofloxacin twice daily in the treatment of patients with acute uncomplicated pyelonephritis.
Bach D; van den Berg-Segers A; Hübner A; van Breukelen G; Cesana M; Plétan Y
J Urol; 1995 Jul; 154(1):19-24. PubMed ID: 7776420
[TBL] [Abstract][Full Text] [Related]
11. Comparative safety and efficacy of sparfloxacin in the treatment of acute exacerbations of chronic obstructive pulmonary disease: a double-blind, randomised, parallel, multicentre study.
Allegra L; Konietzko N; Leophonte P; Hosie J; Pauwels R; Guyen JN; Petitpretz P
J Antimicrob Chemother; 1996 May; 37 Suppl A():93-104. PubMed ID: 8737129
[TBL] [Abstract][Full Text] [Related]
12. Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study.
Grassi C; Albera C; Pozzi E
Am J Med; 1992 Apr; 92(4A):103S-107S. PubMed ID: 1316058
[TBL] [Abstract][Full Text] [Related]
13. Rufloxacin once daily in acute exacerbations of chronic bronchitis.
Dirksen M; Focht J; Boerema J
Infection; 1991; 19(4):297-300. PubMed ID: 1917050
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
Antimicrob Agents Chemother; 1995 Nov; 39(11):2528-34. PubMed ID: 8585739
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia.
O'Doherty B; Dutchman DA; Pettit R; Maroli A
J Antimicrob Chemother; 1997 Dec; 40 Suppl A():73-81. PubMed ID: 9484876
[TBL] [Abstract][Full Text] [Related]
16. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with secondary bacterial infections of acute bronchitis.
Henry D; Ruoff GE; Rhudy J; Puopolo A; Drehobl M; Schoenberger J; Giguere G; Collins JJ
Clin Ther; 1995; 17(5):861-74. PubMed ID: 8595638
[TBL] [Abstract][Full Text] [Related]
17. Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitis.
Mertens JC; van Barneveld PW; Asin HR; Ligtvoet E; Visser MR; Branger T; Hoepelman AI
Antimicrob Agents Chemother; 1992 Jul; 36(7):1456-9. PubMed ID: 1324645
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of fleroxacin versus amoxicillin in acute exacerbations of chronic bronchitis.
Chodosh S
Am J Med; 1993 Mar; 94(3A):131S-135S. PubMed ID: 8452169
[TBL] [Abstract][Full Text] [Related]
19. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.
Langan CE; Zuck P; Vogel F; McIvor A; Peirzchala W; Smakal M; Staley H; Marr C
J Antimicrob Chemother; 1999 Oct; 44(4):515-23. PubMed ID: 10588313
[TBL] [Abstract][Full Text] [Related]
20. Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults. Sparfloxacin European Study Group.
Aubier M; Verster R; Regamey C; Geslin P; Vercken JB
Clin Infect Dis; 1998 Jun; 26(6):1312-20. PubMed ID: 9636854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
